Methinks
About Methinks
Methinks AI is a pioneering digital health company specializing in artificial intelligence software for the early assessment and triage of stroke and other neurovascular emergencies. Their flagship product, Methinks Stroke Suite, is the first CE-marked medical device capable of detecting large vessel occlusions (LVOs), both hyperdense and non-hyperdense, as well as intracerebral hemorrhages (ICH) using non-contrast computed tomography (NCCT). This technology is designed to optimize stroke patient triage and significantly reduce time to treatment, thereby improving clinical outcomes.
The company’s solutions are particularly valuable in settings where advanced imaging techniques like CT angiography are not always available, as they leverage widely accessible NCCT scans. Methinks AI’s engine has demonstrated a nearly 50% reduction in false negatives compared to existing NCCT triage tools for LVO detection. The software integrates with existing hospital workflows, including Microsoft Teams, to provide real-time alerts and streamline communication among healthcare professionals, facilitating faster decision-making and care coordination. Methinks AI aims to provide universal and timely diagnosis to enable life-saving treatments worldwide, with a primary focus on stroke, a leading cause of death and disability.
Focus Areas
Business Intelligence
| Technology | AI algorithms for medical imaging analysis, cloud-based communication system, Microsoft Teams integration |
What Physicians Need to Know
For physicians, Methinks AI offers a crucial advantage by enabling rapid and accurate stroke assessment using widely available non-contrast CT scans, even in facilities without advanced imaging capabilities. This can significantly reduce time to treatment, which is critical for improving patient outcomes in acute stroke cases. The integration with Microsoft Teams facilitates seamless communication and coordination within stroke teams and across different hospitals, ensuring that critical information and AI analysis results are accessible instantly. The ability to detect subtle and distal LVOs, which are often missed by traditional methods, can lead to more timely and appropriate interventions. Physicians can expect a streamlined workflow with real-time AI alerts and comprehensive imaging tools directly within their existing communication platforms.
Methinks AI is designed to integrate seamlessly into existing hospital workflows. It works within Microsoft Teams, allowing for real-time collaboration and access to AI results and imaging tools without installing additional applications. The solution can connect with systems like PACS, DICOM, and Epic, ensuring that the AI agent can access necessary context and write results back into the systems where they are needed. This cloud-based implementation requires minimal on-site infrastructure, making deployment easier for hospitals.
What the Web Says
Methinks (methinks.ai) appears to be a company with two distinct offerings: an AI-powered stroke detection software for healthcare and a qualitative research-as-a-service (RaaS) platform for customer insights. The healthcare AI product has received FDA clearance and positive attention for its ability to detect strokes using non-contrast CT scans, potentially improving patient outcomes, especially in underserved areas. The qualitative research platform, on the other hand, helps businesses conduct live video interviews, surveys, and longitudinal studies to gather customer feedback. Reviews for the research platform are generally positive regarding ease of use and effectiveness, though some users note a limited number of opportunities for participants.
Overall: MixedStrengths
- AI-powered stroke detection software can significantly reduce false negatives and improve stroke care, particularly in hospitals without advanced imaging.
- The stroke detection software integrates seamlessly into existing hospital workflows and PACS systems.
- The qualitative research platform is easy to use for creating gigs, finding respondents, scheduling, and payments.
- The research platform provides effective results for consumer satisfaction surveys and user stories.
- The company culture is described as a great team with a purposeful mission to help people.
- Offers flexible schedule and hybrid work model for employees.
Limitations
- The qualitative research platform can be expensive.
- Some users of the research platform report infrequent new gigs and a lack of notification for unaccepted applications.
- The user base for the research platform still needs to grow for faster turnaround times.
- Reddit discussions from several years ago indicate that the Methinks app for participants had limited opportunities and might not be worth the time for earning money.
- No readily available employer reviews on Glassdoor or similar platforms were found, beyond testimonials on their own website.
- One Capterra review suggested picking other options before choosing Methinks.
Based on reviews from: aistartupseo.com, capterra.ca, med-tech.world, saaskart.co, softwareadvice.com, microsoft.com, trustpilot.com, g2.com, salary.com, researchgate.net, reddit.com, indeed.com, capterra.in
Last updated: 2026-10-29
Videos
News, demos, and interviews about Methinks.
Videos load interactively. If none appear, search YouTube for Methinks →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Methinks.
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]